<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Arch Immunol Ther Exp (Warsz)</journal-id>
<journal-id journal-id-type="iso-abbrev">Arch. Immunol. Ther. Exp. (Warsz.)</journal-id>
<journal-title-group>
<journal-title>Archivum Immunologiae et Therapiae Experimentalis</journal-title>
</journal-title-group>
<issn pub-type="ppub">0004-069X</issn>
<issn pub-type="epub">1661-4917</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31578596</article-id>
<article-id pub-id-type="pmc">6805802</article-id>
<article-id pub-id-type="publisher-id">561</article-id>
<article-id pub-id-type="doi">10.1007/s00005-019-00561-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gut Microbiota in Neurological Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0335-4632</contrib-id>
<name>
<surname>Grochowska</surname>
<given-names>Marta</given-names>
</name>
<address>
<email>marta.grochowska@wum.edu.pl</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laskus</surname>
<given-names>Tomasz</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Radkowski</surname>
<given-names>Marek</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.13339.3b</institution-id><institution-id institution-id-type="ISNI">0000000113287408</institution-id><institution>Department of Immunopathology of Infectious and Parasitic Diseases, </institution><institution>Medical University of Warsaw, </institution></institution-wrap>Warsaw, Poland </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.13339.3b</institution-id><institution-id institution-id-type="ISNI">0000000113287408</institution-id><institution>Department of Adult Infectious Diseases, </institution><institution>Medical University of Warsaw, </institution></institution-wrap>Warsaw, Poland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>1</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>67</volume>
<issue>6</issue>
<fpage>375</fpage>
<lpage>383</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">The incidence of neurological disorders such as multiple sclerosis (MS), Alzheimer’s disease (AD) and Parkinson’s disease (PD) is increasing throughout the world, but their pathogenesis remains unclear and successful treatment remains elusive. Bidirectional communications between the central nervous system and gut microbiota may play some role in the pathogenesis of the above disorders. Up to a thousand bacterial species reside in human intestine; they colonize the gut shortly after birth and remain for life. Numerous studies point to the role of microbiota composition in the development, course and treatment of MS, AD and PD.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Gut</kwd>
<kwd>Microbiota</kwd>
<kwd>Neurological disorders</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">The purpose of this review is to summarize the current knowledge about the role of gut microbiota composition in the development, course, and prognosis of selected neurological diseases. Global incidence of a number of common neurological disorders is rapidly increasing (Bengmark <xref ref-type="bibr" rid="CR12">2013</xref>) and consumption of industrially manipulated meat, dairy and wheat products, which lead to changes in gut microbiota, could be contributing factors (Bengmark <xref ref-type="bibr" rid="CR11">2007</xref>). Understanding the effects of diet on human gut microbiota is therefore of major importance (Kau et al. <xref ref-type="bibr" rid="CR62">2011</xref>).</p>
<p id="Par3">The central nervous system (CNS) and the gut microbiota interact in a bidirectional manner, e.g. the CNS modulates gut functioning in response to psychological and physical stressors affecting motility, secretion and immune reactivity (Mayer <xref ref-type="bibr" rid="CR85">2000</xref>), whereas changes in gut microbiota may cause behavioural and neurochemical changes (Bravo et al. <xref ref-type="bibr" rid="CR14">2011</xref>). Consequently, the term microbiota–gut–brain (MGB) axis was proposed to stress the importance of these interactions (Collins et al. <xref ref-type="bibr" rid="CR22">2012</xref>; Rhee et al. <xref ref-type="bibr" rid="CR102">2009</xref>). the MGB regulates the gastrointestinal (GI) tract and CNS (Dinan et al. <xref ref-type="bibr" rid="CR27">2014</xref>) by way of the vagus nerve, hypothalamic–pituitary–adrenal axis and various cytokines (Dinan et al. <xref ref-type="bibr" rid="CR27">2014</xref>; Jones et al. <xref ref-type="bibr" rid="CR57">2006</xref>).</p>
<p id="Par4">Up to a thousand bacterial species live in human intestine (Mazmanian et al. <xref ref-type="bibr" rid="CR86">2008</xref>), and as many as 10<sup>11</sup> bacteria cells can be found in 1 g of colon contents (Guarner and Malagelada <xref ref-type="bibr" rid="CR48">2003</xref>). This particular ecosystem includes not only bacteria, which are often unculturable (Xu et al. <xref ref-type="bibr" rid="CR123">2007</xref>), but also viruses, protozoa, archae and fungi (Dinan and Cryan <xref ref-type="bibr" rid="CR25">2012</xref>). Commensal bacteria colonize the human intestine shortly after birth and remain there for life (Foster and McVey Neufeld <xref ref-type="bibr" rid="CR39">2013</xref>). The most common phyla are <italic>Firmicutes</italic> and <italic>Bacteroidetes</italic>, which represent 70–75% of total microbiome defined as genetic material of all intestinal microbes. Other bacteria occurring in lower quantities are <italic>Proteobacteria, Actinobacteria, Fusobacteria</italic> and <italic>Verrucomicrobia</italic> (Eckburg et al. <xref ref-type="bibr" rid="CR28">2005</xref>). The microbiome composition is affected by diet, metabolism, age, geography, stress and antibiotic treatment (Foster and McVey Neufeld <xref ref-type="bibr" rid="CR39">2013</xref>). For example <italic>Bacteroides spp.</italic> dominate in people on long-term protein and animal fat diet, whereas <italic>Prevotella spp.</italic> dominate in those on carbohydrate diet (Wu et al. <xref ref-type="bibr" rid="CR122">2011</xref>).</p>
<p id="Par5">Intestinal microbiota can modulate gut functioning, e.g. <italic>Bifidobacterium bifidum</italic> and <italic>Lactobacillus acidophilus</italic> promote motility (Rhee et al. <xref ref-type="bibr" rid="CR102">2009</xref>), whereas <italic>Escherichia</italic> species exert the opposite effect (Mazmanian et al. <xref ref-type="bibr" rid="CR86">2008</xref>; Rhee et al. <xref ref-type="bibr" rid="CR102">2009</xref>). Gut dysbiosis, which is defined as a major shift in microbial composition and function (Fond et al. <xref ref-type="bibr" rid="CR36">2015</xref>) can cause diarrhea or constipation (Rhee et al. <xref ref-type="bibr" rid="CR102">2009</xref>), but even small changes in the gut microbiota can provoke clinical symptoms (Bravo et al. <xref ref-type="bibr" rid="CR15">2012</xref>). Overall, microbiota composition is highly individualized and dynamic (Foster and McVey Neufeld <xref ref-type="bibr" rid="CR39">2013</xref>).</p>
<p id="Par6">Intestinal mucosa, which represents a barrier between the internal and external environments, is subjected to stress (Haq et al. <xref ref-type="bibr" rid="CR49">2019</xref>). This barrier function is supported by diverse bacteria forming commensal microflora (Brown <xref ref-type="bibr" rid="CR16">2016</xref>). The intestinal mucosa is responsible for absorption of water, nutrients and gases, clearance of waste, maintenance of immunity and much more (Haussner et al. <xref ref-type="bibr" rid="CR51">2019</xref>). Intestinal mucosa, gut microbiota, immune cells in the mucosa and various products of epithelial origin are all components of the so called “gut barrier”. If the integrity of the latter becomes compromised, leaky gut syndrome (LGS) ensues leading to systemic- and neuroinflammation and causing dysfunction in the cerebellum and hippocampus (Bengmark <xref ref-type="bibr" rid="CR12">2013</xref>; Daulatzai <xref ref-type="bibr" rid="CR23">2014</xref>; Farhadi et al. <xref ref-type="bibr" rid="CR32">2003</xref>). Importantly, patients with many CNS disorders were found to have increased intestinal permeability (Maes et al. <xref ref-type="bibr" rid="CR80">2012</xref>), and passing of harmful metabolites from intestine to blood can negatively affect the CNS (Julio-Pieper et al. <xref ref-type="bibr" rid="CR58">2014</xref>). Due to the damaged intestinal barrier, lipopolysaccharides (LPS), which are large molecules found in the outer membrane of Gram-negative bacteria, or even whole bacteria (Bengmark <xref ref-type="bibr" rid="CR12">2013</xref>), may enter the bloodstream causing endotoxemia and activating the immune system (Bengmark <xref ref-type="bibr" rid="CR12">2013</xref>). Intestinal permeability can be assessed by functional tests (sucrose test and cellobiose plus mannitol test), serological tests (antibodies to food antigens, autoantibodies), as well as by other markers (e.g. Zonulin serum levels) (Julio-Pieper et al. <xref ref-type="bibr" rid="CR58">2014</xref>).</p>
<p id="Par7">While dysfunction in microbiota could play a role in the development of some neurological diseases, there is also mounting evidence that interventions restoring its health and intestinal barrier integrity can positively affect clinical course and symptoms (Julio-Pieper et al. <xref ref-type="bibr" rid="CR58">2014</xref>). The most common treatments targeting gut dysbiosis are probiotics, which are defined as living organisms providing health benefits to the host (Bravo et al. <xref ref-type="bibr" rid="CR15">2012</xref>), and antibiotics.</p>
</sec>
<sec id="Sec2">
<title>Multiple Sclerosis</title>
<p id="Par8">Multiple sclerosis (MS) is the most common neurological disease of young adults in Europe and North America (Keegan and Noseworthy <xref ref-type="bibr" rid="CR63">2002</xref>). It is characterized by an autoimmune inflammatory process in which CD4<sup>+</sup>CD25<sup>+</sup> regulatory T (Treg) cells target brain and spinal cord cells leading to demyelination and axonal damage (Lavasani et al. <xref ref-type="bibr" rid="CR74">2010</xref>; Tremlett et al. <xref ref-type="bibr" rid="CR114">2016b</xref>).</p>
<p id="Par9">A combination of genetic and environmental factors is likely to be involved in MS pathogenesis (Granieri et al. <xref ref-type="bibr" rid="CR46">2000</xref>), but none has been found to be essential (Tremlett and Waubant <xref ref-type="bibr" rid="CR112">2017</xref>). There is mounting evidence that an important role could be played by changes in the gut microbiome (Adamczyk-Sowa et al. <xref ref-type="bibr" rid="CR1">2017</xref>). While the specific mechanisms have not been elucidated as yet (Forbes et al. <xref ref-type="bibr" rid="CR37">2016</xref>), it seems that gut microbiota changes can cause a pro-inflammatory state resulting in CNS damage, the culmination of which is the development of MS (Adamczyk-Sowa et al. <xref ref-type="bibr" rid="CR1">2017</xref>; Rodriguez et al. <xref ref-type="bibr" rid="CR105">2016</xref>).</p>
<p id="Par10">Bacteria species likely to be involved are <italic>Helicobacter, Clostridium</italic> and <italic>Enterococcus</italic> (Round and Mazmanian <xref ref-type="bibr" rid="CR106">2009</xref>). It was also shown that segmented filamentous bacteria can activate intestinal Th17 cells, which promote systemic autoimmunity and participate in immune response against intestinal pathogens (Atarashi et al. <xref ref-type="bibr" rid="CR6">2011</xref>). However, some findings point also to the ability of specific bacteria to provide anti-inflammatory effects (Adamczyk-Sowa et al. <xref ref-type="bibr" rid="CR1">2017</xref>). For example, <italic>Bacteroides fragilis’</italic> polysaccharide product was found to be able to modulate systemic Th1 and mucosal Treg cell responses in mice (Mazmanian et al. <xref ref-type="bibr" rid="CR86">2008</xref>).</p>
<p id="Par11">Compared to healthy controls, MS patients have a decrease in the proportion of <italic>Faecalibacterium, Eubacterium rectale, Corynebacterium, Fusobacteria</italic> and an increase of <italic>Escherichia, Shigella, Clostridium, Firmicutes</italic> (Cantarel et al. <xref ref-type="bibr" rid="CR19">2015</xref>; Tremlett et al. <xref ref-type="bibr" rid="CR113">2016a</xref>, <xref ref-type="bibr" rid="CR115">c</xref>). Decreased numbers of <italic>Faecalibacterium</italic> spp. and lower levels of its metabolite butyrate lead to decrease of Treg cells, antigen-presenting cells, and pro-inflammatory cytokines (Adamczyk-Sowa et al. <xref ref-type="bibr" rid="CR1">2017</xref>; Machiels et al. <xref ref-type="bibr" rid="CR79">2014</xref>). Several authors reported a decrease of such <italic>Bacteroides</italic> spp. as <italic>Bacteroides stercoris and Bacteroides coprocola</italic> in the gut microbiota of MS patients and a negative correlation between the number of <italic>Prevotella copri</italic> and the risk of MS development (Miyake et al. <xref ref-type="bibr" rid="CR89">2015</xref>).</p>
<p id="Par12">Tremlett et al. (<xref ref-type="bibr" rid="CR114">2016b</xref>) found no differences in immune markers such as the number of Th2, Th17 and Tregs cells between children with MS and healthy controls. However, abundance of gut microbiota correlated positively with Th17 in affected children, but not in controls, whereas <italic>Bacteroidetes</italic> spp. numbers correlated inversely with Th17. The abundance of <italic>Fusobacteria</italic> correlated positively with Tregs only in controls.</p>
<p id="Par13">Some bacterial products could play a role in the communication between the gut and brain. For example, serum levels of <italic>Bactroidetes</italic> spp. metabolite lipid 654 were found to be significantly lower in MS patients than in healthy controls, and are even regarded by some as an MS biomarker (Farrokhi et al. <xref ref-type="bibr" rid="CR33">2013</xref>; Kleinewietfeld et al. <xref ref-type="bibr" rid="CR65">2013</xref>). Another example is <italic>Clostridium perfringens</italic> toxins B and D (Uzal et al. <xref ref-type="bibr" rid="CR119">2004</xref>), which are able to induce such symptoms as lack of movement coordination or blurred vision, which are similar to MS (Adamczyk-Sowa et al. <xref ref-type="bibr" rid="CR1">2017</xref>). In MS patients these toxins may cause inflammation of the retina by affecting the barrier veins or by binding to vascular system receptors (Barnett et al. <xref ref-type="bibr" rid="CR8">2009</xref>; Fennessey et al. <xref ref-type="bibr" rid="CR35">2012</xref>; Nagahama and Sakurai <xref ref-type="bibr" rid="CR92">1992</xref>). Toxins of <italic>C. perfringens</italic> are not detectable in healthy subjects (Adamczyk-Sowa et al. <xref ref-type="bibr" rid="CR1">2017</xref>; Murrell et al. <xref ref-type="bibr" rid="CR91">1986</xref>; Rumah et al. <xref ref-type="bibr" rid="CR107">2013</xref>).</p>
<p id="Par14">Studies on the role of gut microbiota in experimental autoimmune encephalomyelitis (EAE), which is the most widely used animal model of MS, showed that oral treatment with ampicillin, vancomycin, neomycin, sulfate, and metronidazole can delay the onset and reduce the severity of the disease, decrease levels of pro-inflammatory cytokines and increase levels of interleukin (IL)-10 and IL-13 (Ochoa-Reparaz et al. <xref ref-type="bibr" rid="CR95">2009</xref>).</p>
<p id="Par15">Administration of probiotics (IRT5 containing <italic>Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus reuteni, Bifidobacterium bifidum,</italic> and <italic>Streptococcus thermophilus</italic>) before the induction of EAE resulted in its delayed onset and milder course (Forbes et al. <xref ref-type="bibr" rid="CR37">2016</xref>; Kwon et al. <xref ref-type="bibr" rid="CR70">2013</xref>). In another experiment, treatment by probiotics containing <italic>Lactobacillus paracasei</italic> and <italic>L. plantarum</italic> suppressed the development of EAE and reduced severity of clinical symptoms while increasing the number of Treg cells in mesenteric lymph nodes, and increasing production of transforming growth factor β1 and IL-27. Interestingly, this effect was not observed when the two bacteria species were administered separately (Forbes et al. <xref ref-type="bibr" rid="CR37">2016</xref>; Lavasani et al. <xref ref-type="bibr" rid="CR74">2010</xref>).</p>
<p id="Par16">The effects of microbiota therapeutic interventions in humans have not been studied extensively. However, MS patients who underwent fecal microbiota transplantation showed amelioration of neurologic symptoms and improvement of life quality (Evrensel and Ceylan <xref ref-type="bibr" rid="CR31">2016</xref>), but these studies were too small to be conclusive. It should be stressed that unhealthy life style choices such as high consumption of salt, animal fat, carbohydrates and low physical activity negatively affect gut microbiota composition and metabolism leading to LGS and exacerbation of MS symptoms (Adamczyk-Sowa et al. <xref ref-type="bibr" rid="CR1">2017</xref>; Riccio and Rossano <xref ref-type="bibr" rid="CR103">2015</xref>).</p>
</sec>
<sec id="Sec3">
<title>Alzheimer’s Disease</title>
<p id="Par17">Alzheimer’s disease (AD) is a common neurodegenerative disease of the elderly accounting for 60–80% of all dementia cases (Alzheimer’s Association <xref ref-type="bibr" rid="CR4">2015</xref>; Hu et al. <xref ref-type="bibr" rid="CR54">2016</xref>). It is expected that the number of patients with dementia worldwide will double every 20 years reaching 115 millions in 2050 (Prince et al. <xref ref-type="bibr" rid="CR98">2013</xref>). AD is characterized by the accumulation in the cerebral cortex and other brain regions of misfolded amyloid-β (Aβ) fibrils and oligomers, such as neurofibrillary tangles consisting of hyperphosphorylated tau protein (Mager et al. <xref ref-type="bibr" rid="CR81">2014</xref>). There is also evidence for the presence of neuroinflammation and prion-like pathology (Scheperjans <xref ref-type="bibr" rid="CR108">2016a</xref>), which are being intensively studied to identify potential causes (Tremlett et al. <xref ref-type="bibr" rid="CR116">2017</xref>). It is currently believed that both environmental and genetic factors are involved in the pathogenesis of AD (Hu et al. <xref ref-type="bibr" rid="CR54">2016</xref>).</p>
<p id="Par18">Clearly, some role in the pathogenesis could be played by LGS, which causes increased permeability of blood–brain barrier (BBB), Aβ accumulation in brain and inflammatory response (Hu et al. <xref ref-type="bibr" rid="CR54">2016</xref>). LPS, which elicit strong immune responses (Bengmark <xref ref-type="bibr" rid="CR12">2013</xref>) were found to be elevated in AD patients (Zhang et al. <xref ref-type="bibr" rid="CR128">2009</xref>), while in mice models LPS increases Aβ levels in the brain (Jaeger et al. <xref ref-type="bibr" rid="CR56">2009</xref>) and causes severe memory loss (Kahn et al. <xref ref-type="bibr" rid="CR59">2012</xref>).</p>
<p id="Par19">High-fat and/or high-calorie diet seems to be a risk factor for AD development (Eskelinen et al. <xref ref-type="bibr" rid="CR29">2008</xref>; Knight et al. <xref ref-type="bibr" rid="CR66">2014</xref>). Diet can affect gut microbiota in multiple ways; for example gluten and sugars stimulate systemic inflammation and consequently affect CNS functions (Hu et al. <xref ref-type="bibr" rid="CR54">2016</xref>). Such components of diet as deep-sea fish, nuts, and vegetable oils (Gu et al. <xref ref-type="bibr" rid="CR47">2010</xref>), which are all major dietary sources of Omega 3 polyunsaturated fatty acids (ω-3 PUFAs) can lower the risk of AD (Morris et al. <xref ref-type="bibr" rid="CR90">2003</xref>), and AD patients often demonstrate low levels of DHA (docosahexaenoic acid), which is one of the ω-3 PUFAs. Importantly, gut microbiota is involved in the absorption and metabolism of ω-3 PUFAs (Hu et al. <xref ref-type="bibr" rid="CR54">2016</xref>; Tully et al. <xref ref-type="bibr" rid="CR117">2003</xref>).</p>
<p id="Par20">PUFAs include such important compounds as essential fatty acids (EFA), which are not synthetized by humans (Yehuda et al. <xref ref-type="bibr" rid="CR126">2005</xref>). EFA affect brain function and seem to be important for many brain disorders (Yehuda et al. <xref ref-type="bibr" rid="CR126">2005</xref>). Since EFA and PUFAs must be derived from food, they are capable of crossing the BBB. Decreased brain levels of EFA, especially in the cortex and hippocampus, which mediate learning and memory, were reported in AD patients, and this deficiency was likely due to the reduction in their ability to cross the BBB (Yehuda et al. <xref ref-type="bibr" rid="CR126">2005</xref>). Decreased brain EFA levels are likely to play a role in cognitive decline (Yehuda et al. <xref ref-type="bibr" rid="CR125">2002</xref>).</p>
<p id="Par21">Fruits and vegetables lower the risk of AD probably by providing antioxidants and vitamins (Hughes et al. <xref ref-type="bibr" rid="CR55">2010</xref>). The same effect could be conferred by antioxidant polyphenols found in coffee, which reduce brain injury caused by oxidative stress (Hu et al. <xref ref-type="bibr" rid="CR54">2016</xref>). Accordingly, it was reported that drinking three to five cups daily decreases the risk of AD by 65% compared to drinking less than two cups per day (Eskelinen et al. <xref ref-type="bibr" rid="CR30">2009</xref>). Diet and specific nutrients seem to affect gut microbiota composition and influence the production and aggregation of amyloid proteins (Friedland <xref ref-type="bibr" rid="CR41">2015</xref>; Scott et al. <xref ref-type="bibr" rid="CR111">2013</xref>).</p>
<p id="Par22">Amyloid-β accumulation is the cornerstone feature of AD, but the exact mechanisms behind this phenomenon are not fully understood (Cattaneo et al. <xref ref-type="bibr" rid="CR21">2017</xref>). Cognitively impaired patients with brain Aβ deposition were reported to have lower stool abundance of anti-inflammatory <italic>E. rectale</italic> and <italic>B. fragilis</italic> and higher abundance of pro-inflammatory <italic>Escherichia</italic> spp. and S<italic>higella</italic> spp. when compared to cognitively impaired patients with no Aβ deposition or healthy controls (Cattaneo et al. <xref ref-type="bibr" rid="CR21">2017</xref>; Mancuso and Santangelo <xref ref-type="bibr" rid="CR83">2018</xref>). These differences could be reflected in the inflammatory state, as the first group was reported to have higher levels of pro-inflammatory cytokines (IL-6, CXCL2, NLRP3, and IL-1β) and lower levels of anti-inflammatory IL-10 (Cattaneo et al. <xref ref-type="bibr" rid="CR21">2017</xref>).</p>
<p id="Par23"><italic>Lactobacillus</italic> spp. and <italic>Bifidobacterium</italic> spp. can produce gamma-Aminobutyric acid (GABA) (Barrett et al. <xref ref-type="bibr" rid="CR9">2012</xref>) and may improve cognitive functioning of AD patients when used as probiotics. <italic>Post mortem</italic> studies of AD brains showed reduced GABA concentrations in many cortical and limbic regions (cingulate, amygdala and thalamus) (Lanctot et al. <xref ref-type="bibr" rid="CR72">2004</xref>).</p>
<p id="Par24">Cognitive decline is the key feature of AD (Archer et al. <xref ref-type="bibr" rid="CR3">2011</xref>; Carlino et al. <xref ref-type="bibr" rid="CR20">2013</xref>) and it has been found that it impairs life quality much more than other behavioural or even psychotic symptoms (Nuechterlein et al. <xref ref-type="bibr" rid="CR94">2011</xref>). Cognitive disturbances may be associated with altered activity of various growth factors, including neurotrophins such as brain-derived neurotrophic factor (BDNF) (Carlino et al. <xref ref-type="bibr" rid="CR20">2013</xref>). BDNF is involved in such processes as neuronal development and differentiation, as well as synaptic plasticity (Carlino et al. <xref ref-type="bibr" rid="CR20">2013</xref>) and its expression may be modulated by gut microbiota: it was reported that specific pathogen-free mice have higher BDNF mRNA levels in the hippocampus and amygdala compared to germ-free animals (Diaz Heijtz et al. <xref ref-type="bibr" rid="CR24">2011</xref>). <italic>Post mortem</italic> studies of AD brains showed a 30% decrease in the amount of proBDNF compared to controls and this decrease was as high as 40% in end-stage patients (Michalski and Fahnestock <xref ref-type="bibr" rid="CR87">2003</xref>). BDNF serum levels in AD patients are lower than in subjects with other types of dementia or healthy controls (Carlino et al. <xref ref-type="bibr" rid="CR20">2013</xref>; Nieto et al. <xref ref-type="bibr" rid="CR93">2013</xref>). However, while serum levels of BDNF are easy measured, they are neither predictive of AD development nor correlate with Functional Assessment Staging (Laske et al. <xref ref-type="bibr" rid="CR73">2006</xref>; Yasutake et al. <xref ref-type="bibr" rid="CR124">2006</xref>).</p>
<p id="Par25">There is some evidence that bacteria and bacterial endotoxins may be directly involved in the pathogenesis of AD (Asti and Gioglio <xref ref-type="bibr" rid="CR5">2014</xref>). Thus, it was reported that infusion of LPS into the fourth ventricle in rats causes brain changes similar to those found in AD patients (Asti and Gioglio <xref ref-type="bibr" rid="CR5">2014</xref>). In human studies, transcriptionally active <italic>Chlamydia pneumoniae</italic> was detected in autopsy brains tissue of AD patients (Balin et al. <xref ref-type="bibr" rid="CR7">1998</xref>) and Spirochaetes (<italic>Borrelia burgdorferi, Treponema pallidum</italic>) were found in cerebrospinal fluid and the cerebral cortex of patients with general paresis suggesting that these bacteria might play a role in slowly progressive dementia, cortical atrophy, and local amyloidosis (Asti and Gioglio <xref ref-type="bibr" rid="CR5">2014</xref>; Miklossy <xref ref-type="bibr" rid="CR88">2011</xref>). Furthermore, serum IgG and IgA against <italic>Helicobacter pylori</italic> were reported to be more common in AD patients (Malaguarnera et al. <xref ref-type="bibr" rid="CR82">2004</xref>), while <italic>Escherichia coli</italic> endotoxin may facilitate formation of Aβ fibrils in vitro (Asti and Gioglio <xref ref-type="bibr" rid="CR5">2014</xref>).</p>
<p id="Par26">The gut microbiota may influence AD in various ways. Most notably, paucity of gut bacteria may contribute to the development of this disease as a negative correlation was observed between the incidence of AD and microbiota diversity. In the developed countries with high level of hygiene and consequently decreased microbial diversity, the incidence of AD is increasing (Fox et al. <xref ref-type="bibr" rid="CR40">2013</xref>). Also bacterial products such as amyloids and LPS, may accumulate in the blood and brain and contribute to the pathological features of AD (Zhao and Lukiw <xref ref-type="bibr" rid="CR130">2015</xref>). Some bacteria species, e.g. <italic>Firmicutes, Bacteroidetes</italic>, <italic>Proteobacteria,</italic> produce amyloids inducing pro-inflammatory IL-17A and IL-22 cytokines, which are linked to chronic inflammatory diseases, including AD (Hill and Lukiw <xref ref-type="bibr" rid="CR52">2015</xref>; Zhang et al. <xref ref-type="bibr" rid="CR129">2013</xref>). Further, gut microbiota changes may cause activation of pro-inflammatory cytokines and consequently increase intestinal permeability (Bekkering et al. <xref ref-type="bibr" rid="CR10">2013</xref>), especially in forms of AD characterized by pronounced learning problems and memory loss (Hu et al. <xref ref-type="bibr" rid="CR54">2016</xref>). Finally, the gut microbiota is responsible for the production of such vitamins as B12, which reduces the risk of dementia (Hu et al. <xref ref-type="bibr" rid="CR54">2016</xref>) and AD (Quadri et al. <xref ref-type="bibr" rid="CR99">2004</xref>).</p>
<p id="Par27">Interestingly, administration of <italic>Bifidobacterium lactis</italic> HN019 decreases the levels of pro-inflammatory cytokines IL-5, IL-6, IL-1β, IL-8 and tumor necrosis factor α (Rincon et al. <xref ref-type="bibr" rid="CR104">2014</xref>; Wang et al. <xref ref-type="bibr" rid="CR121">2015</xref>). It was also shown that probiotics are able to increase the levels of anti-inflammatory cells (total, helper CD4<sup>+</sup>, and activated CD4<sup>+</sup>CD25<sup>+</sup> T cells in the peripheral circulation) (Gill et al. <xref ref-type="bibr" rid="CR45">2001</xref>; Pistollato et al. <xref ref-type="bibr" rid="CR96">2016</xref>).</p>
</sec>
<sec id="Sec4">
<title>Parkinson’s Disease</title>
<p id="Par28">The mean time from diagnosis to death in Parkinson’s disease (PD), the second most common neurodegenerative disorder of elderly, is 15 years (Forsyth et al. <xref ref-type="bibr" rid="CR38">2011</xref>; Katzenschlager et al. <xref ref-type="bibr" rid="CR61">2008</xref>; Lees et al. <xref ref-type="bibr" rid="CR77">2009</xref>). PD prevalence is approximately 0.4% and the number of cases is predicted to double by the year 2040 (Adams-Carr et al. <xref ref-type="bibr" rid="CR2">2016</xref>; Kowal et al. <xref ref-type="bibr" rid="CR67">2013</xref>). The median age for the onset of PD is 60 years and the ensuing disabilities are characterized by motor and non-motor symptoms including dementia, which is life-threatening condition (Hobson et al. <xref ref-type="bibr" rid="CR53">2010</xref>; Marras and Lang <xref ref-type="bibr" rid="CR84">2008</xref>). The majority of PD cases are diagnosed on the basis of neurological symptoms such as tremor, bradykinesia, rigidity, when a significant proportion of neurons within the substantia nigra is already damaged (Adams-Carr et al. <xref ref-type="bibr" rid="CR2">2016</xref>; Forsyth et al. <xref ref-type="bibr" rid="CR38">2011</xref>).</p>
<p id="Par29">The key feature of PD is the presence of neuronal inclusions (Lewy Bodies or Lewy neurites) consisting of aggregated and phosphorylated α-synuclein (Braak and Del Tredici <xref ref-type="bibr" rid="CR13">2008</xref>). While the cause of PD remains unknown, the GI tract is the source of many toxins affecting the CNS (Julio-Pieper et al. <xref ref-type="bibr" rid="CR58">2014</xref>) and interacts with the brain by the dorsal motor nucleus of the vagus nerve. The latter nucleus seems to be the earliest site of Lewy Bodies expression in the course of the disease (Braak and Del Tredici <xref ref-type="bibr" rid="CR13">2008</xref>; Forsyth et al. <xref ref-type="bibr" rid="CR38">2011</xref>). Several studies reported on the presence of Lewy Bodies in the esophagus and colon (Kupsky et al. <xref ref-type="bibr" rid="CR69">1987</xref>; Lebouvier et al. <xref ref-type="bibr" rid="CR75">2008</xref>, <xref ref-type="bibr" rid="CR76">2010</xref>; Qualman et al. <xref ref-type="bibr" rid="CR100">1984</xref>), which suggests that GI tract is somehow involved in the pathogenesis of PD.</p>
<p id="Par30">Non-motor symptoms, including mood and cognitive impairment, sleep disorders, sensory disruption and GI dysfunction (Postuma et al. <xref ref-type="bibr" rid="CR97">2012</xref>), are common in PD and can severely impact patients’ quality of life (Gallagher et al. <xref ref-type="bibr" rid="CR44">2010</xref>). The second most common non-motor symptom after anosmia is constipation affecting 50% of patients. It is also a strong risk factor for PD (Adams-Carr et al. <xref ref-type="bibr" rid="CR2">2016</xref>). Moreover, functional and structural changes in GI tissues, such as α-synuclein accumulation in the enteric nervous system (ENS) have been described in PD patients (Visanji et al. <xref ref-type="bibr" rid="CR120">2015</xref>). The ENS is responsible for normal gut functioning and represents a way by which commensal bacteria regulate many physiological functions, including intestinal motility (Kunze et al. <xref ref-type="bibr" rid="CR68">2009</xref>).</p>
<p id="Par31">Gut microbiota abnormalities are common in PD patients and their relation to brain dysfunction is being intensively investigated (Scheperjans <xref ref-type="bibr" rid="CR109">2016b</xref>). In three different studies of fecal microbiota composition there was a decreased representation of bacteria <italic>Prevotellaceae, Coprococcus, Firmicutes, Clostridium coccoides, Clostridium leptum, B. fragilis</italic> and increased representation of <italic>Lactobacillaceae, Verrucomicrobiaceae, Ruminococcaceae, Lactobacuillus, Bacteroidetes, Proteobacteria, Clostridiaceae</italic> and <italic>Akkermansia</italic> (Hasegawa et al. <xref ref-type="bibr" rid="CR50">2015</xref>; Keshavarzian et al. <xref ref-type="bibr" rid="CR64">2015</xref>; Scheperjans et al. <xref ref-type="bibr" rid="CR110">2015</xref>). The increase in abundance of <italic>Lactobacillaceae</italic> could affect the ENS as these bacteria were found to increase the excitability of colonic after-hyperpolarization neurons by inhibiting calcium-dependent potassium channel opening (Kunze et al. <xref ref-type="bibr" rid="CR68">2009</xref>). <italic>Lactobacillus</italic> spp. quantity and serum leptin concentrations were found to be positively correlated (Queipo-Ortuno et al. <xref ref-type="bibr" rid="CR101">2013</xref>) while the decreased abundance of <italic>Prevotellaceae</italic> and increased abundance of <italic>Lactobacillaceae</italic> have been correlated with decreased levels of gut ghrelin. The latter hormone may regulate nigrostriatal dopamine function and restrict neurodegeneration in PD (Queipo-Ortuno et al. <xref ref-type="bibr" rid="CR101">2013</xref>; Scheperjans et al. <xref ref-type="bibr" rid="CR110">2015</xref>) and its secretion is decreased in PD patients (Unger et al. <xref ref-type="bibr" rid="CR118">2011</xref>). Although the diminished <italic>Prevotellaceae</italic> levels are not specific for PD and were reported in other diseases such as autistic spectrum disorders (Kang et al. <xref ref-type="bibr" rid="CR60">2013</xref>) or type 1 diabetes (Brown et al. <xref ref-type="bibr" rid="CR17">2011</xref>), increased fecal <italic>Prevotellaceae</italic> levels have been proposed as an excluding biomarker of PD (Scheperjans et al. <xref ref-type="bibr" rid="CR110">2015</xref>). Thus, the quantity of these bacteria was 77.6% lower in PD patients when compared to sex- and age-matched controls. Relative abundance of <italic>Prevotellaceae</italic> below 6.5% was found to be diagnostic of PD with 86.1% sensitivity and 38.9% specificity (Dinan and Cryan <xref ref-type="bibr" rid="CR26">2017</xref>). It was also reported that high levels of <italic>Enterobacteriaceae</italic> positively correlate with the severity of postural instability and gait difficulty (Scheperjans et al. <xref ref-type="bibr" rid="CR110">2015</xref>) supporting the existence of a link between gut microbiota composition and motor disturbances in PD.</p>
<p id="Par32">Initial studies employing per os administration of hydrogen water in rats (Fu et al. <xref ref-type="bibr" rid="CR42">2009</xref>) and mice (Fujita et al. <xref ref-type="bibr" rid="CR43">2009</xref>) demonstrated its protective role in animal models of PD and a subsequent double-blind, randomized, controlled study in humans showed that 1000 ml of hydrogen water per day improved the total Unified Parkinson’s Disease Rating Scale scores (Yoritaka et al. <xref ref-type="bibr" rid="CR127">2013</xref>). Consequently, the hydrogen-producing bacteria were analyzed in PD patients. There was a decrease of six bacterial groups producing hydrogen: <italic>B</italic>. <italic>fragilis</italic>, <italic>C</italic>. <italic>perfringens</italic>, <italic>Pseudomonas spp.,</italic> most strains in <italic>Enterobacteriaceae</italic> family, 12 species in <italic>Clostridium</italic>, <italic>C</italic>. <italic>coccoides</italic> group and <italic>C</italic>. <italic>leptum</italic> subgroup (Hasegawa et al. <xref ref-type="bibr" rid="CR50">2015</xref>).</p>
<p id="Par33">Interestingly, small intestinal bacterial overgrowth was found to contribute to the pathophysiology of motor fluctuation in PD patients and eradication of bacterial overgrowth resulted in clinical improvement (Fasano et al. <xref ref-type="bibr" rid="CR34">2013</xref>), and it was also reported that patients with irritable bowel syndrome have an increased risk of developing PD (Lai et al. <xref ref-type="bibr" rid="CR71">2014</xref>). It has been proposed that gut microbiota in PD patients are shifted towards pro-inflammatory state, since certain genes related to the production of LPS and “pro-inflammatory” bacterial taxes like <italic>Akkermansia</italic> and <italic>Ralstonia</italic> were found to be increased in affected patients (Scheperjans <xref ref-type="bibr" rid="CR109">2016b</xref>).</p>
<p id="Par34">Some authors also found an increase in gut permeability in patients with PD when using the urinary sucralose test (Julio-Pieper et al. <xref ref-type="bibr" rid="CR58">2014</xref>). This could results in passing of harmful substances into circulation (Forsyth et al. <xref ref-type="bibr" rid="CR38">2011</xref>).</p>
</sec>
<sec id="Sec5">
<title>Conclusions</title>
<p id="Par35">There was a 90% decrease of plant fiber intake between 1800 and 1970, while the consumption of calories from animal fat and refined sugar increased four times in this time period (Burkitt et al. <xref ref-type="bibr" rid="CR18">1972</xref>). As the concentration of plant fiber in our diet fell below 20% (Bengmark <xref ref-type="bibr" rid="CR12">2013</xref>), the GI transit time increased five-fold (Burkitt et al. <xref ref-type="bibr" rid="CR18">1972</xref>). These Western dietary habits caused a decrease both in absolute number and diversity of gut bacteria (Bengmark <xref ref-type="bibr" rid="CR12">2013</xref>).</p>
<p id="Par36">There is ample evidence for the existence of communication between CNS, gut and intestinal microbiome (Rhee et al. <xref ref-type="bibr" rid="CR102">2009</xref>) and analysis of relationships between gut microbiota composition and CNS disorders has become a novel and promising field of research, which could provide understanding of disease pathogenesis and offer new and effective treatment options (Table <xref ref-type="table" rid="Tab1">1</xref>) (Julio-Pieper et al. <xref ref-type="bibr" rid="CR58">2014</xref>; Luna and Foster <xref ref-type="bibr" rid="CR78">2015</xref>; Scheperjans <xref ref-type="bibr" rid="CR109">2016b</xref>). Future clinical studies of microbiota manipulations should be based on randomised, controlled trials.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Factors affecting the function of Central Nervous System (diet, metabolites, hormones, immune modulators, which can be modified by gut microbiota) and gut microbiota disturbances in multiple sclerosis, Alzheimer’s disease, Parkinson’s disease</p></caption><graphic id="MO1" position="anchor" xlink:href="5_2019_561_Tab1_HTML"></graphic><table-wrap-foot><p><italic>GABA</italic> gamma-aminobutyric acid, <italic>BDNF</italic> brain-derived neurotrophic factor, <italic>DHA</italic> docosahexaenoic acid, <italic>ω-3 PUFA</italic> omega 3 polyunsaturated fatty acids, <italic>EFA</italic> essential fatty acids, <italic>Aβ</italic> amyloid-β, <italic>LPS</italic> lipopolysaccharides, <italic>LGS</italic> leaky gut syndrome; <italic>CNS</italic> central nervous system, <italic>LB</italic> Lewy bodies, <italic>LN</italic> Lewy neuritis, <italic>ENS</italic> enteric nervous system, <italic>PD</italic> Parkinson’s disease</p></table-wrap-foot></table-wrap></p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Publisher's Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<notes notes-type="ethics">
<title>Compliance with ethical standards</title>
<notes notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par37">The authors declare no conflict of interests.</p>
</notes>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adamczyk-Sowa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Medrek</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Does the gut microbiota influence immunity and inflammation in multiple sclerosis pathophysiology?</article-title>
<source/>J Immunol Res
          <year>2017</year>
<volume>2017</volume>
<fpage>7904821</fpage>
<pub-id pub-id-type="pmid">28316999</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams-Carr</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Bestwick</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Constipation preceding Parkinson’s disease: a systematic review and meta-analysis</article-title>
<source/>J Neurol Neurosurg Psychiatry
          <year>2016</year>
<volume>87</volume>
<fpage>710</fpage>
<lpage>716</lpage>
<pub-id pub-id-type="pmid">26345189</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Alzheimer’s Association</collab>
</person-group>
<article-title>2015 Alzheimer’s disease facts and figures</article-title>
<source/>Alzheimers Dement
          <year>2015</year>
<volume>11</volume>
<fpage>332</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="pmid">25984581</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Archer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kostrzewa</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Beninger</surname>
<given-names>RJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions</article-title>
<source/>Neurotox Res
          <year>2011</year>
<volume>19</volume>
<fpage>211</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="pmid">20393891</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gioglio</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?</article-title>
<source/>J Alzheimers Dis
          <year>2014</year>
<volume>39</volume>
<fpage>169</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="pmid">24150108</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atarashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanoue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shima</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of colonic regulatory T cells by indigenous Clostridium species</article-title>
<source/>Science
          <year>2011</year>
<volume>331</volume>
<fpage>337</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="pmid">21205640</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balin</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Gerard</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>EJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification and localization of <italic>Chlamydia pneumoniae</italic> in the Alzheimer’s brain</article-title>
<source/>Med Microbiol Immunol
          <year>1998</year>
<volume>187</volume>
<fpage>23</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">9749980</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnett</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Parratt</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>ES</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunoglobulins and complement in postmortem multiple sclerosis tissue</article-title>
<source/>Ann Neurol
          <year>2009</year>
<volume>65</volume>
<fpage>32</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">19194879</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrett</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>O’Toole</surname>
<given-names>PW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>gamma-Aminobutyric acid production by culturable bacteria from the human intestine</article-title>
<source/>J Appl Microbiol
          <year>2012</year>
<volume>113</volume>
<fpage>411</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="pmid">22612585</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bekkering</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jafri</surname>
<given-names>I</given-names>
</name>
<name>
<surname>van Overveld</surname>
<given-names>FJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes</article-title>
<source/>Expert Rev Clin Immunol
          <year>2013</year>
<volume>9</volume>
<fpage>1031</fpage>
<lpage>1041</lpage>
<pub-id pub-id-type="pmid">24138599</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bengmark</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Advanced glycation and lipoxidation end products–amplifiers of inflammation: the role of food</article-title>
<source/>JPEN J Parenter Enteral Nutr
          <year>2007</year>
<volume>31</volume>
<fpage>430</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="pmid">17712153</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bengmark</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Gut microbiota, immune development and function</article-title>
<source/>Pharmacol Res
          <year>2013</year>
<volume>69</volume>
<fpage>87</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="pmid">22989504</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Del Tredici</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Invited article: nervous system pathology in sporadic Parkinson disease</article-title>
<source/>Neurology
          <year>2008</year>
<volume>70</volume>
<fpage>1916</fpage>
<lpage>1925</lpage>
<pub-id pub-id-type="pmid">18474848</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bravo</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Forsythe</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>MV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2011</year>
<volume>108</volume>
<fpage>16050</fpage>
<lpage>16055</lpage>
<pub-id pub-id-type="pmid">21876150</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bravo</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Julio-Pieper</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Forsythe</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Communication between gastrointestinal bacteria and the nervous system</article-title>
<source/>Curr Opin Pharmacol
          <year>2012</year>
<volume>12</volume>
<fpage>667</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="pmid">23041079</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Catecholamine-directed epithelial cell interactions with bacteria in the intestinal mucosa</article-title>
<source/>Adv Exp Med Biol
          <year>2016</year>
<volume>874</volume>
<fpage>79</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">26589214</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Davis-Richardson</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Giongo</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e25792</fpage>
<pub-id pub-id-type="pmid">22043294</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burkitt</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Painter</surname>
<given-names>NS</given-names>
</name>
</person-group>
<article-title>Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease</article-title>
<source/>Lancet
          <year>1972</year>
<volume>2</volume>
<fpage>1408</fpage>
<lpage>1412</lpage>
<pub-id pub-id-type="pmid">4118696</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cantarel</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Waubant</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chehoud</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota in multiple sclerosis: possible influence of immunomodulators</article-title>
<source/>J Investig Med
          <year>2015</year>
<volume>63</volume>
<fpage>729</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="pmid">25775034</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlino</surname>
<given-names>D</given-names>
</name>
<name>
<surname>De Vanna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tongiorgi</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?</article-title>
<source/>Neuroscientist
          <year>2013</year>
<volume>19</volume>
<fpage>345</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="pmid">23242909</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cattaneo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cattane</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Galluzzi</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly</article-title>
<source/>Neurobiol Aging
          <year>2017</year>
<volume>49</volume>
<fpage>60</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">27776263</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Surette</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bercik</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The interplay between the intestinal microbiota and the brain</article-title>
<source/>Nat Rev Microbiol
          <year>2012</year>
<volume>10</volume>
<fpage>735</fpage>
<lpage>742</lpage>
<pub-id pub-id-type="pmid">23000955</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daulatzai</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Role of stress, depression, and aging in cognitive decline and Alzheimer’s disease</article-title>
<source/>Curr Top Behav Neurosci
          <year>2014</year>
<volume>18</volume>
<fpage>265</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="pmid">25167923</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz Heijtz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Normal gut microbiota modulates brain development and behavior</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2011</year>
<volume>108</volume>
<fpage>3047</fpage>
<lpage>3052</lpage>
<pub-id pub-id-type="pmid">21282636</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology</article-title>
<source/>Psychoneuroendocrinology
          <year>2012</year>
<volume>37</volume>
<fpage>1369</fpage>
<lpage>1378</lpage>
<pub-id pub-id-type="pmid">22483040</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<mixed-citation publication-type="other">Dinan TG, Cryan JF (2017) Gut feelings on Parkinson’s and depression. Cerebrum pii: cer-04-17 <bold>(eCollection 2017)</bold></mixed-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Borre</surname>
<given-names>YE</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Genomics of schizophrenia: time to consider the gut microbiome?</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>1252</fpage>
<lpage>1257</lpage>
<pub-id pub-id-type="pmid">25288135</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckburg</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Bik</surname>
<given-names>EM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diversity of the human intestinal microbial flora</article-title>
<source/>Science
          <year>2005</year>
<volume>308</volume>
<fpage>1635</fpage>
<lpage>1638</lpage>
<pub-id pub-id-type="pmid">15831718</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eskelinen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Ngandu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Helkala</surname>
<given-names>EL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study</article-title>
<source/>Int J Geriatr Psychiatry
          <year>2008</year>
<volume>23</volume>
<fpage>741</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="pmid">18188871</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eskelinen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Ngandu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tuomilehto</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study</article-title>
<source/>J Alzheimers Dis
          <year>2009</year>
<volume>16</volume>
<fpage>85</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">19158424</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evrensel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ceylan</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Fecal microbiota transplantation and its usage in neuropsychiatric disorders</article-title>
<source/>Clin Psychopharmacol Neurosci
          <year>2016</year>
<volume>14</volume>
<fpage>231</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="pmid">27489376</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farhadi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Banan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fields</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal barrier: an interface between health and disease</article-title>
<source/>J Gastroenterol Hepatol
          <year>2003</year>
<volume>18</volume>
<fpage>479</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="pmid">12702039</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farrokhi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Nemati</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>FC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bacterial lipodipeptide, lipid 654, is a microbiome-associated biomarker for multiple sclerosis</article-title>
<source/>Clin Transl Immunology
          <year>2013</year>
<volume>2</volume>
<fpage>e8</fpage>
<pub-id pub-id-type="pmid">25505950</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fasano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bove</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gabrielli</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of small intestinal bacterial overgrowth in Parkinson’s disease</article-title>
<source/>Mov Disord
          <year>2013</year>
<volume>28</volume>
<fpage>1241</fpage>
<lpage>1249</lpage>
<pub-id pub-id-type="pmid">23712625</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fennessey</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>DH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oligomerization of <italic>Clostridium perfringens</italic> epsilon toxin is dependent upon caveolins 1 and 2</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e46866</fpage>
<pub-id pub-id-type="pmid">23056496</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fond</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Boukouaci</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Chevalier</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The “psychomicrobiotic”: targeting microbiota in major psychiatric disorders: a systematic review</article-title>
<source/>Pathol Biol
          <year>2015</year>
<volume>63</volume>
<fpage>35</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">25468489</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forbes</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Van Domselaar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>CN</given-names>
</name>
</person-group>
<article-title>The gut microbiota in immune-mediated inflammatory diseases</article-title>
<source/>Front Microbiol
          <year>2016</year>
<volume>7</volume>
<fpage>1081</fpage>
<pub-id pub-id-type="pmid">27462309</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forsyth</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Shannon</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Kordower</surname>
<given-names>JH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e28032</fpage>
<pub-id pub-id-type="pmid">22145021</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>McVey Neufeld</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>Gut-brain axis: how the microbiome influences anxiety and depression</article-title>
<source/>Trends Neurosci
          <year>2013</year>
<volume>36</volume>
<fpage>305</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="pmid">23384445</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Knapp</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>PW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hygiene and the world distribution of Alzheimer’s disease: epidemiological evidence for a relationship between microbial environment and age-adjusted disease burden</article-title>
<source/>Evol Med Public Health
          <year>2013</year>
<volume>2013</volume>
<fpage>173</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="pmid">24481197</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedland</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Mechanisms of molecular mimicry involving the microbiota in neurodegeneration</article-title>
<source/>J Alzheimers Dis
          <year>2015</year>
<volume>45</volume>
<fpage>349</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="pmid">25589730</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson’s disease</article-title>
<source/>Neurosci Lett
          <year>2009</year>
<volume>453</volume>
<fpage>81</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">19356598</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujita</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Seike</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yutsudo</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease</article-title>
<source/>PLoS One
          <year>2009</year>
<volume>4</volume>
<fpage>e7247</fpage>
<pub-id pub-id-type="pmid">19789628</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallagher</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Schrag</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them?</article-title>
<source/>Mov Disord
          <year>2010</year>
<volume>25</volume>
<fpage>2493</fpage>
<lpage>2500</lpage>
<pub-id pub-id-type="pmid">20922807</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gill</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Rutherfurd</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enhancement of immunity in the elderly by dietary supplementation with the probiotic <italic>Bifidobacterium lactis</italic> HN019</article-title>
<source/>Am J Clin Nutr
          <year>2001</year>
<volume>74</volume>
<fpage>833</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="pmid">11722966</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granieri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Casetta</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Govoni</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The increasing incidence and prevalence of MS in a Sardinian province</article-title>
<source/>Neurology
          <year>2000</year>
<volume>55</volume>
<fpage>842</fpage>
<lpage>848</lpage>
<pub-id pub-id-type="pmid">10994006</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nieves</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Food combination and Alzheimer disease risk: a protective diet</article-title>
<source/>Arch Neurol
          <year>2010</year>
<volume>67</volume>
<fpage>699</fpage>
<lpage>706</lpage>
<pub-id pub-id-type="pmid">20385883</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guarner</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Malagelada</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Gut flora in health and disease</article-title>
<source/>Lancet
          <year>2003</year>
<volume>361</volume>
<fpage>512</fpage>
<lpage>519</lpage>
<pub-id pub-id-type="pmid">12583961</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haq</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grondin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Banskota</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autophagy: roles in intestinal mucosal homeostasis and inflammation</article-title>
<source/>J Biomed Sci
          <year>2019</year>
<volume>26</volume>
<fpage>19</fpage>
<pub-id pub-id-type="pmid">30764829</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasegawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<fpage>e0142164</fpage>
<pub-id pub-id-type="pmid">26539989</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haussner</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Halbgebauer</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Challenge to the intestinal mucosa during sepsis</article-title>
<source/>Front Immunol
          <year>2019</year>
<volume>10</volume>
<fpage>891</fpage>
<pub-id pub-id-type="pmid">31114571</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Microbial-generated amyloids and Alzheimer’s disease (AD)</article-title>
<source/>Front Aging Neurosci
          <year>2015</year>
<volume>7</volume>
<fpage>9</fpage>
<pub-id pub-id-type="pmid">25713531</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hobson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Meara</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ishihara-Paul</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The estimated life expectancy in a community cohort of Parkinson’s disease patients with and without dementia, compared with the UK population</article-title>
<source/>J Neurol Neurosurg Psychiatry
          <year>2010</year>
<volume>81</volume>
<fpage>1093</fpage>
<lpage>1098</lpage>
<pub-id pub-id-type="pmid">20571039</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease and gut microbiota</article-title>
<source/>Sci China Life Sci
          <year>2016</year>
<volume>59</volume>
<fpage>1006</fpage>
<lpage>1023</lpage>
<pub-id pub-id-type="pmid">27566465</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Andel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Small</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Midlife fruit and vegetable consumption and risk of dementia in later life in Swedish twins</article-title>
<source/>Am J Geriatr Psychiatry
          <year>2010</year>
<volume>18</volume>
<fpage>413</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="pmid">19910881</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaeger</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Dohgu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sultana</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer’s disease</article-title>
<source/>Brain Behav Immun
          <year>2009</year>
<volume>23</volume>
<fpage>507</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="pmid">19486646</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Dilley</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Drossman</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain-gut connections in functional GI disorders: anatomic and physiologic relationships</article-title>
<source/>Neurogastroenterol Motil
          <year>2006</year>
<volume>18</volume>
<fpage>91</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="pmid">16420287</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Julio-Pieper</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bravo</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Aliaga</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Review article: intestinal barrier dysfunction and central nervous system disorders—a controversial association</article-title>
<source/>Aliment Pharmacol Ther
          <year>2014</year>
<volume>40</volume>
<fpage>1187</fpage>
<lpage>1201</lpage>
<pub-id pub-id-type="pmid">25262969</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahn</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Kranjac</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Alonzo</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prolonged elevation in hippocampal Abeta and cognitive deficits following repeated endotoxin exposure in the mouse</article-title>
<source/>Behav Brain Res
          <year>2012</year>
<volume>229</volume>
<fpage>176</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="pmid">22249135</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Ilhan</surname>
<given-names>ZE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e68322</fpage>
<pub-id pub-id-type="pmid">23844187</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katzenschlager</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Head</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schrag</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD</article-title>
<source/>Neurology
          <year>2008</year>
<volume>71</volume>
<fpage>474</fpage>
<lpage>480</lpage>
<pub-id pub-id-type="pmid">18579806</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kau</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Ahern</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>NW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human nutrition, the gut microbiome and the immune system</article-title>
<source/>Nature
          <year>2011</year>
<volume>474</volume>
<fpage>327</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="pmid">21677749</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keegan</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Noseworthy</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis</article-title>
<source/>Annu Rev Med
          <year>2002</year>
<volume>53</volume>
<fpage>285</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="pmid">11818475</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keshavarzian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Engen</surname>
<given-names>PA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Colonic bacterial composition in Parkinson’s disease</article-title>
<source/>Mov Disord
          <year>2015</year>
<volume>30</volume>
<fpage>1351</fpage>
<lpage>1360</lpage>
<pub-id pub-id-type="pmid">26179554</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinewietfeld</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Manzel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Titze</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells</article-title>
<source/>Nature
          <year>2013</year>
<volume>496</volume>
<fpage>518</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="pmid">23467095</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knight</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Gümüsgöz</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology</article-title>
<source/>Neurobiol Aging
          <year>2014</year>
<volume>35</volume>
<fpage>1821</fpage>
<lpage>1832</lpage>
<pub-id pub-id-type="pmid">24630364</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kowal</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Dall</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The current and projected economic burden of Parkinson’s disease in the United States</article-title>
<source/>Mov Disord
          <year>2013</year>
<volume>28</volume>
<fpage>311</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="pmid">23436720</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunze</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening</article-title>
<source/>J Cell Mol Med
          <year>2009</year>
<volume>13</volume>
<fpage>2261</fpage>
<lpage>2270</lpage>
<pub-id pub-id-type="pmid">19210574</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kupsky</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Grimes</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Sweeting</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells</article-title>
<source/>Neurology
          <year>1987</year>
<volume>37</volume>
<fpage>1253</fpage>
<lpage>1255</lpage>
<pub-id pub-id-type="pmid">3037441</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response</article-title>
<source/>Clin Immunol
          <year>2013</year>
<volume>146</volume>
<fpage>217</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">23416238</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in Taiwan</article-title>
<source/>Eur J Epidemiol
          <year>2014</year>
<volume>29</volume>
<fpage>57</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">24442494</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanctot</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mazzotta</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GABAergic function in Alzheimer’s disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia</article-title>
<source/>Can J Psychiatry
          <year>2004</year>
<volume>49</volume>
<fpage>439</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="pmid">15362248</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laske</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stransky</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Leyhe</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Stage-dependent BDNF serum concentrations in Alzheimer’s disease</article-title>
<source/>J Neural Transm
          <year>2006</year>
<volume>113</volume>
<fpage>1217</fpage>
<lpage>1224</lpage>
<pub-id pub-id-type="pmid">16362629</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lavasani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dzhambazov</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nouri</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<fpage>e9009</fpage>
<pub-id pub-id-type="pmid">20126401</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebouvier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chaumette</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Damier</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathological lesions in colonic biopsies during Parkinson’s disease</article-title>
<source/>Gut
          <year>2008</year>
<volume>57</volume>
<fpage>1741</fpage>
<lpage>1743</lpage>
<pub-id pub-id-type="pmid">19022934</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebouvier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Neunlist</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bruley des Varannes</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Colonic biopsies to assess the neuropathology of Parkinson’s disease and its relationship with symptoms</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<fpage>e12728</fpage>
<pub-id pub-id-type="pmid">20856865</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Revesz</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Parkinson’s disease</article-title>
<source/>Lancet
          <year>2009</year>
<volume>373</volume>
<fpage>2055</fpage>
<lpage>2066</lpage>
<pub-id pub-id-type="pmid">19524782</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luna</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression</article-title>
<source/>Curr Opin Biotechnol
          <year>2015</year>
<volume>32</volume>
<fpage>35</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">25448230</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machiels</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Joossens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sabino</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A decrease of the butyrate-producing species <italic>Roseburia hominis and Faecalibacterium prausnitzii</italic> defines dysbiosis in patients with ulcerative colitis</article-title>
<source/>Gut
          <year>2014</year>
<volume>63</volume>
<fpage>1275</fpage>
<lpage>1283</lpage>
<pub-id pub-id-type="pmid">24021287</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kubera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leunis</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut</article-title>
<source/>J Affect Disord
          <year>2012</year>
<volume>141</volume>
<fpage>55</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">22410503</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mager</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>From gut to brain: bioencapsulated therapeutic protein reduces amyloid load upon oral delivery</article-title>
<source/>Mol Ther
          <year>2014</year>
<volume>22</volume>
<fpage>485</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="pmid">24584078</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malaguarnera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bella</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alagona</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>Helicobacter pylori</italic> and Alzheimer’s disease: a possible link</article-title>
<source/>Eur J Intern Med
          <year>2004</year>
<volume>15</volume>
<fpage>381</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="pmid">15522573</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mancuso</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Santangelo</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease and gut microbiota modifications: the long way between preclinical studies and clinical evidence</article-title>
<source/>Pharmacol Res
          <year>2018</year>
<volume>129</volume>
<fpage>329</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="pmid">29233677</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marras</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain</article-title>
<source/>Neurology
          <year>2008</year>
<volume>70</volume>
<fpage>1996</fpage>
<lpage>2003</lpage>
<pub-id pub-id-type="pmid">18490620</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>The neurobiology of stress and gastrointestinal disease</article-title>
<source/>Gut
          <year>2000</year>
<volume>47</volume>
<fpage>861</fpage>
<lpage>869</lpage>
<pub-id pub-id-type="pmid">11076888</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Round</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>A microbial symbiosis factor prevents intestinal inflammatory disease</article-title>
<source/>Nature
          <year>2008</year>
<volume>453</volume>
<fpage>620</fpage>
<lpage>625</lpage>
<pub-id pub-id-type="pmid">18509436</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michalski</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fahnestock</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer’s disease</article-title>
<source/>Brain Res Mol Brain Res
          <year>2003</year>
<volume>111</volume>
<fpage>148</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="pmid">12654514</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miklossy</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Emerging roles of pathogens in Alzheimer disease</article-title>
<source/>Expert Rev Mol Med
          <year>2011</year>
<volume>13</volume>
<fpage>e30</fpage>
<pub-id pub-id-type="pmid">21933454</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyake</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suda</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<fpage>e0137429</fpage>
<pub-id pub-id-type="pmid">26367776</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Bienias</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease</article-title>
<source/>Arch Neurol
          <year>2003</year>
<volume>60</volume>
<fpage>940</fpage>
<lpage>946</lpage>
<pub-id pub-id-type="pmid">12873849</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murrell</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>O’Donoghue</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>A review of the sheep-multiple sclerosis connection</article-title>
<source/>Med Hypotheses
          <year>1986</year>
<volume>19</volume>
<fpage>27</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">2871478</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagahama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>High-affinity binding of <italic>Clostridium perfringens</italic> epsilon-toxin to rat brain</article-title>
<source/>Infect Immun
          <year>1992</year>
<volume>60</volume>
<fpage>1237</fpage>
<lpage>1240</lpage>
<pub-id pub-id-type="pmid">1541539</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieto</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kukuljan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory</article-title>
<source/>Front Psychiatry
          <year>2013</year>
<volume>4</volume>
<fpage>45</fpage>
<pub-id pub-id-type="pmid">23785335</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nuechterlein</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Subotnik</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>MF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurocognitive predictors of work outcome in recent-onset schizophrenia</article-title>
<source/>Schizophr Bull
          <year>2011</year>
<volume>37</volume>
<issue>Suppl 2</issue>
<fpage>S33</fpage>
<lpage>S40</lpage>
<pub-id pub-id-type="pmid">21860045</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochoa-Reparaz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mielcarz</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Ditrio</surname>
<given-names>LE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis</article-title>
<source/>J Immunol
          <year>2009</year>
<volume>183</volume>
<fpage>6041</fpage>
<lpage>6050</lpage>
<pub-id pub-id-type="pmid">19841183</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pistollato</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sumalla Cano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Elio</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease</article-title>
<source/>Nutr Rev
          <year>2016</year>
<volume>74</volume>
<fpage>624</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="pmid">27634977</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Postuma</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Aarsland</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Barone</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease</article-title>
<source/>Mov Disord
          <year>2012</year>
<volume>27</volume>
<fpage>617</fpage>
<lpage>626</lpage>
<pub-id pub-id-type="pmid">22508280</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prince</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bryce</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The global prevalence of dementia: a systematic review and metaanalysis</article-title>
<source/>Alzheimers Dement
          <year>2013</year>
<volume>9</volume>
<fpage>63</fpage>
<lpage>75.e2</lpage>
<pub-id pub-id-type="pmid">23305823</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quadri</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fragiacomo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pezzati</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia</article-title>
<source/>Am J Clin Nutr
          <year>2004</year>
<volume>80</volume>
<fpage>114</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">15213037</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qualman</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Haupt</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson’s disease</article-title>
<source/>Gastroenterology
          <year>1984</year>
<volume>87</volume>
<fpage>848</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="pmid">6088351</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Queipo-Ortuno</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Seoane</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Murri</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e65465</fpage>
<pub-id pub-id-type="pmid">23724144</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhee</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Pothoulakis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Principles and clinical implications of the brain-gut-enteric microbiota axis</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2009</year>
<volume>6</volume>
<fpage>306</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="pmid">19404271</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riccio</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rossano</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Nutrition facts in multiple sclerosis</article-title>
<source/>ASN Neuro
          <year>2015</year>
<volume>7</volume>
<fpage>1759091414568185</fpage>
<pub-id pub-id-type="pmid">25694551</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rincon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vaquero</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hernando</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites</article-title>
<source/>Liver Int
          <year>2014</year>
<volume>34</volume>
<fpage>1504</fpage>
<lpage>1512</lpage>
<pub-id pub-id-type="pmid">24661740</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wootla</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis, gut microbiota and permeability: role of tryptophan catabolites, depression and the driving down of local melatonin</article-title>
<source/>Curr Pharm Des
          <year>2016</year>
<volume>22</volume>
<fpage>6134</fpage>
<lpage>6141</lpage>
<pub-id pub-id-type="pmid">27634184</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Round</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>The gut microbiota shapes intestinal immune responses during health and disease</article-title>
<source/>Nat Rev Immunol
          <year>2009</year>
<volume>9</volume>
<fpage>313</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="pmid">19343057</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rumah</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Linden</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fischetti</surname>
<given-names>VA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Isolation of <italic>Clostridium perfringens</italic> type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e76359</fpage>
<pub-id pub-id-type="pmid">24146858</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheperjans</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Can microbiota research change our understanding of neurodegenerative diseases?</article-title>
<source/>Neurodegener Dis Manag
          <year>2016</year>
<volume>6</volume>
<fpage>81</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">27033377</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheperjans</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Gut microbiota, 1013 new pieces in the Parkinson’s disease puzzle</article-title>
<source/>Curr Opin Neurol
          <year>2016</year>
<volume>29</volume>
<fpage>773</fpage>
<lpage>780</lpage>
<pub-id pub-id-type="pmid">27653288</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheperjans</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aho</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota are related to Parkinson’s disease and clinical phenotype</article-title>
<source/>Mov Disord
          <year>2015</year>
<volume>30</volume>
<fpage>350</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="pmid">25476529</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Gratz</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>PO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The influence of diet on the gut microbiota</article-title>
<source/>Pharmacol Res
          <year>2013</year>
<volume>69</volume>
<fpage>52</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">23147033</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Waubant</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The multiple sclerosis microbiome?</article-title>
<source/>Ann Transl Med
          <year>2017</year>
<volume>5</volume>
<fpage>53</fpage>
<pub-id pub-id-type="pmid">28251132</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fadrosh</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Faruqi</surname>
<given-names>AA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota composition and relapse risk in pediatric MS: a pilot study</article-title>
<source/>J Neurol Sci
          <year>2016</year>
<volume>363</volume>
<fpage>153</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">27000242</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fadrosh</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Faruqi</surname>
<given-names>AA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls</article-title>
<source/>BMC Neurol
          <year>2016</year>
<volume>16</volume>
<fpage>182</fpage>
<pub-id pub-id-type="pmid">27652609</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fadrosh</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Faruqi</surname>
<given-names>AA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota in early pediatric multiple sclerosis: a case-control study</article-title>
<source/>Eur J Neurol
          <year>2016</year>
<volume>23</volume>
<fpage>1308</fpage>
<lpage>1321</lpage>
<pub-id pub-id-type="pmid">27176462</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Appel-Cresswell</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiome in human neurological disease: a review</article-title>
<source/>Ann Neurol
          <year>2017</year>
<volume>81</volume>
<fpage>369</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="pmid">28220542</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tully</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer’s disease: a case-control study</article-title>
<source/>Br J Nutr
          <year>2003</year>
<volume>89</volume>
<fpage>483</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="pmid">12654166</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unger</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Mankel</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?</article-title>
<source/>J Neurol
          <year>2011</year>
<volume>258</volume>
<fpage>982</fpage>
<lpage>990</lpage>
<pub-id pub-id-type="pmid">21181542</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uzal</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>WE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The pathology of peracute experimental <italic>Clostridium perfringens</italic> type D enterotoxemia in sheep</article-title>
<source/>J Vet Diagn Investig
          <year>2004</year>
<volume>16</volume>
<fpage>403</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="pmid">15460322</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visanji</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Marras</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>DS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease</article-title>
<source/>Neurology
          <year>2015</year>
<volume>84</volume>
<fpage>609</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="pmid">25589666</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>IK</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>YF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial</article-title>
<source/>Benef Microbes
          <year>2015</year>
<volume>6</volume>
<fpage>423</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="pmid">25609654</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linking long-term dietary patterns with gut microbial enterotypes</article-title>
<source/>Science
          <year>2011</year>
<volume>334</volume>
<fpage>105</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="pmid">21885731</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mahowald</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evolution of symbiotic bacteria in the distal human intestine</article-title>
<source/>PLoS Biol
          <year>2007</year>
<volume>5</volume>
<fpage>e156</fpage>
<pub-id pub-id-type="pmid">17579514</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasutake</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yanagawa</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer’s disease and vascular dementia</article-title>
<source/>Eur Arch Psychiatry Clin Neurosci
          <year>2006</year>
<volume>256</volume>
<fpage>402</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="pmid">16783499</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yehuda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rabinovitz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carasso</surname>
<given-names>RL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of polyunsaturated fatty acids in restoring the aging neuronal membrane</article-title>
<source/>Neurobiol Aging
          <year>2002</year>
<volume>23</volume>
<fpage>843</fpage>
<lpage>853</lpage>
<pub-id pub-id-type="pmid">12392789</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yehuda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rabinovitz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mostofsky</surname>
<given-names>DI</given-names>
</name>
</person-group>
<article-title>Essential fatty acids and the brain: from infancy to aging</article-title>
<source/>Neurobiol Aging
          <year>2005</year>
<volume>26</volume>
<issue>Suppl 1</issue>
<fpage>98</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="pmid">16226347</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoritaka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takanashi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hirayama</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pilot study of H(2) therapy in Parkinson’s disease: a randomized double-blind placebo-controlled trial</article-title>
<source/>Mov Disord
          <year>2013</year>
<volume>28</volume>
<fpage>836</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="pmid">23400965</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Gascon</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)</article-title>
<source/>J Neuroimmunol
          <year>2009</year>
<volume>206</volume>
<fpage>121</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="pmid">19013651</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Th17 cell-mediated neuroinflammation is involved in neurodegeneration of abeta1-42-induced Alzheimer’s disease model rats</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<fpage>e75786</fpage>
<pub-id pub-id-type="pmid">24124514</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer’s disease (AD)</article-title>
<source/>J Nat Sci
          <year>2015</year>
<volume>1</volume>
<fpage>e138</fpage>
<pub-id pub-id-type="pmid">26097896</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>